AHA convenes Capitol Hill forum on rural hospital priorities

AHA News Now

Rural hospital and health system leaders today received an update on their legislative and policy priorities at an AHA Rural Hospital Policy Forum before meeting with their representatives on Capitol Hill. Sen. Chuck Grassley (R-IA), lead sponsor of the AHA-supported Rural Emergency Acute Care Hospital... read more

Topic: Advocacy and Public Policy
Tags: 340B, rural, Critical Access Hospitals, access, Telehealth

AHA convenes Capitol Hill forum on rural hospital priorities

AHA News

Rural hospital and health system leaders today received an update on their legislative and policy priorities at an AHA Rural Hospital Policy Forum before meeting with their representatives on Capitol Hill.

Sen. Chuck Grassley (R-IA), lead sponsor of the AHA-supported Rural Emergency Acute Care Hospital... read more

Topics: Access and Coverage, Advocacy and Public Policy
Tags: 340B, rural, access

A vital safety-net program

Blog

The exorbitant cost of many prescription drugs threatens providers’ ability to provide life-saving medications for millions of Americans.

That is why the 340B Drug Pricing Program, which provides discounts on drugs to some health care providers who serve large numbers of low-income and uninsured... read more

Topic: Access and Coverage
Tags: 340B, access

House holds hearing on 340B Drug Pricing Program

AHA News Now

The House Energy & Commerce Subcommittee on Oversight and Investigations today held a hearing to review the Health Resources and Services Administration’s oversight of the 340B Drug Pricing Program and how the program impacts patients, providers, manufacturers and other stakeholders. In comments submitted... read more

Topic: Advocacy and Public Policy
Tags: 340B, Drug Pricing Program

CMS releases 2018 outpatient PPS and physician payment proposed rules

AHA News

The AHA July 13 criticized proposed deep cuts to how much the Centers for Medicare & Medicaid Services reimburses hospitals for drugs acquired under the 340B Drug Pricing Program and proposes changes to site-neutral payment policies under Section 603 of the 2015 Bipartisan Budget Act. The provisions are... read more

Topics: Quality and Patient Safety, Advocacy and Public Policy
Tags: 340B, site neutral payment, Drug Pricing Program, Medicare, regulation

CMS releases 2018 OPPS/ASC proposed rule

AHA News Now

The Centers for Medicare & Medicaid Services today proposed to update hospital outpatient prospective payment system rates by 1.75% in calendar year 2018 compared to CY 2017. The rule also would drastically cut Medicare payment for drugs that are acquired under the 340B Drug Pricing Program. Specifically,... read more

Topic: Advocacy and Public Policy
Tags: 340B, quality, physicians, site neutral payment, Medicare, rural, Critical Access Hospitals, regulation, drug prices

Bill would expand 340B discounts for orphan drugs

AHA News Now

Reps. Peter Welch (D-VT) and Gregg Harper (R-MS) yesterday introduced the Closing Loopholes for Orphan Drugs Act (H.R. 2889, legislation that would limit the “orphan drug” exclusion for 340B Drug Pricing Program rural and cancer hospitals. Specifically, the legislation would allow 340B critical access... read more

Topic: Advocacy and Public Policy
Tags: 340B, rural, Critical Access Hospitals

HRSA delays until Oct. 1 the effective date of final rule on 340B drug ceiling prices

AHA News Now

The Health Resources and Services Administration today delayed to Oct. 1 the effective date of its final rule on 340B drug ceiling prices and civil monetary penalties for manufacturers. The final rule was subject to multiple delays since January. “The additional time provided to the public before the rule... read more

Topic: Advocacy and Public Policy
Tags: 340B, regulation, drug prices

MedPAC finalizes recommendations for Part B drug payment policy

AHA News Now

The Medicare Payment Advisory Commission yesterday finalized a package of recommendations for Congress aimed at reducing the rapid growth in Part B drug spending. The proposals would require all Part B drug manufacturers to submit Average Sales Price data; reduce Wholesale Acquisition Cost-based payment... read more

Topic: Advocacy and Public Policy
Tag: 340B

HRSA further delays effective date of final rule on 340B drug ceiling prices

AHA News Now

The Health Resources and Services Administration today delayed to May 22 the effective date of its final rule on 340B drug ceiling prices and civil monetary penalties for manufacturers, and invited comments on whether a delay to Oct. 1 would be more appropriate. The rule was set to take effect March 21... read more

Topic: Advocacy and Public Policy
Tags: 340B, Drug Pricing Program, regulation, drug prices

Keyword Search

Date